Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon Mar 07, 2021 1:11pm
134 Views
Post# 32739018

RE:RE:RE:RE:Imagine ... all the possibilities

RE:RE:RE:RE:Imagine ... all the possibilities
MrMugsy wrote:
123ABC wrote: Agreed, Mugs always here posting about some old article and all these "endless possibilities" company can't even figure out how to monetize one drug.


Hahaha!
You can keep bashing - don't care.
You don't like the price - too bad.

If I bash - then I'm hated.
If I add to all the thoughts I've had to this point - I'm a pumper.
Again - don't care.

Can't make money worrying about the haters.
In or out?  Pick one.
Hahaha.

I'm in and very happy as we build the value for partnering.
I don't need to get there yesterday ... or tomorrow.
I don't care what the market says the shares are worth.
Has never mattered in my stock picking.

It's the future that matters.  In or out ?  Gotta chose.  I've got lots of reason to be in.

Am I going to convince you to buy - heck no - don't care !!!!!

: )



P.S.  I know you're going to buy ... even if you don't tell anyone !
<< Previous
Bullboard Posts
Next >>